Terms: = Breast cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
416 results:
1. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
2. CD63
Sun J; Du R; Li X; Liu C; Wang D; He X; Li G; Zhang K; Wang S; Hao Q; Zhang Y; Li M; Gao Y; Zhang C
Cancer Lett; 2024 Apr; 588():216747. PubMed ID: 38403110
[TBL] [Abstract] [Full Text] [Related]
3. Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images.
Jimah BB; Amoako E; Ofori EO; Akakpo PK; Aniakwo LA; Ulzen-Appiah K; Imbeah EG; Morna MT; Koggoh P; Akligoh H; Tackie R; Manu A; Paemka L; Sarkodie BD; Offei AK; Hutchful D; Ngoi J; Bediako Y; Rahman GA
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1988. PubMed ID: 38351553
[TBL] [Abstract] [Full Text] [Related]
4. Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors.
Klapp V; Bloy N; Jiménez-Cortegana C; Buqué A; Petroni G
Methods Cell Biol; 2024; 181():197-212. PubMed ID: 38302240
[TBL] [Abstract] [Full Text] [Related]
5. PMM2 controls ERα levels and cell proliferation in ESR1 Y537S variant expressing breast cancer cells.
Cipolletti M; Acconcia F
Mol Cell Endocrinol; 2024 Apr; 584():112160. PubMed ID: 38266771
[TBL] [Abstract] [Full Text] [Related]
6. A new treatment for breast cancer using a combination of two drugs: AZD9496 and palbociclib.
Nave O; Shor Y; Bar R; Segal EE; Sigron M
Sci Rep; 2024 Jan; 14(1):1307. PubMed ID: 38225243
[TBL] [Abstract] [Full Text] [Related]
7. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract] [Full Text] [Related]
8. IGF2BP2 Drives Cell Cycle Progression in Triple-Negative breast cancer by Recruiting EIF4A1 to Promote the m6A-Modified cdk6 Translation Initiation Process.
Xia T; Dai XY; Sang MY; Zhang X; Xu F; Wu J; Shi L; Wei JF; Ding Q
Adv Sci (Weinh); 2024 Jan; 11(1):e2305142. PubMed ID: 37983610
[TBL] [Abstract] [Full Text] [Related]
9. cdk6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma.
Li GS; Huang ZG; Li DM; Tang YL; Zheng JH; Yang L; Feng Y; Peng JX; Li JX; Tang YX; Zeng NY; Jin MH; Tian J; Liu J; Zhou HF; Chen G; Chen F
Funct Integr Genomics; 2023 Nov; 23(4):332. PubMed ID: 37950078
[TBL] [Abstract] [Full Text] [Related]
10. Mahanine mediated therapeutic inhibition of estrogen receptor-α and CDK4/6 expression, decipher the chemoprevention-signaling cascade in preclinical model of breast cancer.
Samanta SK; Choudhury P; Kandimalla R; Aqil F; Moholkar DN; Gupta RC; Das M; Gogoi B; Gogoi N; Sarma PP; Devi R; Talukdar NC
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117235. PubMed ID: 37804924
[TBL] [Abstract] [Full Text] [Related]
11. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
Yousif FA; Alzain AA; Alraih AM; Ibraheem W
PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of SHR5428 as a selective and noncovalent inhibitor of CDK7.
Jia M; Wang W; Chen G; Wu T; Zhang T; Zhou Q; Yin J; Li J; Li X; Mao Y; Feng J; Hu M; Li X; He F
Bioorg Med Chem Lett; 2023 Sep; 93():129429. PubMed ID: 37543274
[TBL] [Abstract] [Full Text] [Related]
13. Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Zeverijn LJ; Looze EJ; Thavaneswaran S; van Berge Henegouwen JM; Simes RJ; Hoes LR; Sjoquist KM; van der Wijngaart H; Sebastian L; Geurts BS; Lee CK; de Wit GF; Espinoza D; Roepman P; Lin FP; Jansen AML; de Leng WWJ; van der Noort V; Leek LVM; de Vos FYFL; van Herpen CML; Gelderblom H; Verheul HMW; Thomas DM; Voest EE
Int J Cancer; 2023 Oct; 153(7):1413-1422. PubMed ID: 37424386
[TBL] [Abstract] [Full Text] [Related]
14. Discovery of dual PARP and cdk6 inhibitors for triple-negative breast cancer with wild-type BRCA.
Wang C; Luo H; Chen X; Zhang Y; Lu D; Liu X; Yin F; Li S; Kong L; Wang X
Bioorg Chem; 2023 Oct; 139():106683. PubMed ID: 37379778
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Beta Blockers on breast cancer Incidence and Prognosis.
Yang J; Zhang S; Jiang W
Clin Breast Cancer; 2023 Aug; 23(6):664-671.e21. PubMed ID: 37353431
[TBL] [Abstract] [Full Text] [Related]
16. Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2/p21 signaling axis.
Liao Y; Li S; An J; Yu X; Tan X; Gui Y; Wang Y; Huang L; Zhou S; Wang D
Phytomedicine; 2023 Jul; 116():154856. PubMed ID: 37187035
[TBL] [Abstract] [Full Text] [Related]
17. Immunomodulatory effects of CDK4/6 inhibitors.
Zhang S; Xu Q; Sun W; Zhou J; Zhou J
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188912. PubMed ID: 37182667
[TBL] [Abstract] [Full Text] [Related]
18. Flap perfusion assessment with indocyanine green angiography in deep inferior epigastric perforator flap breast reconstruction: A systematic review and meta-analysis.
Wang Z; Jiao L; Chen S; Li Z; Xiao Y; Du F; Huang J; Long X
Microsurgery; 2023 Sep; 43(6):627-638. PubMed ID: 37165852
[TBL] [Abstract] [Full Text] [Related]
19. A functional genetic screen for metabolic proteins unveils GART and the
Cipolletti M; Leone S; Bartoloni S; Acconcia F
Front Endocrinol (Lausanne); 2023; 14():1129162. PubMed ID: 37143728
[TBL] [Abstract] [Full Text] [Related]
20. cdk6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation.
Quandt E; Masip N; Hernández-Ortega S; Sánchez-Botet A; Gasa L; Fernández-Elorduy A; Plutta S; Martínez-Láinez JM; Bru S; Munoz-Torres PM; Floor M; Villà-Freixa J; Morris MC; Vidal A; Villanueva A; Clotet J; Ribeiro MPC
Mol Oncol; 2023 Jul; 17(7):1228-1245. PubMed ID: 37081792
[TBL] [Abstract] [Full Text] [Related]
[Next]
